Magnetic resonance imaging for primary breast cancer management: Current role and new applications

Endocrine-Related Cancer

Volumn 9, Issue 2, 2002, Pages 141-153

  Esserman, Laura ^a   Wolverton, D ^a   Hylton, N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM;

ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; ECHOGRAPHY; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING;

EID: 0036324471     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0090141     Document Type: Article

References (54)

1. Multicentric and multifocal cancer: Whole-breast US in preoperative evaluation
2. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection
3. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique
4. Screening mammography in community practice: Positive predictive value of abnormal findings and yield of follow-up diagnostic procedures
5. The impact of alternative practices on the cost and quality of mammographic screening in the United States
6. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
7. Predisposition testing for inherited breast cancer
8. Tumor recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadolinium-enhanced MR imaging
9. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution
10. Percutaneous imaging-guided core breast biopsy. 5 Years experience in a community hospital
11. Likelihood ratios for modern screening mammography: Risk of breast cancer based on age and mammographic interpretation
12. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging
13. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma
14. MRI imaging can predict breast conservation in patients undergoing neoadjuvant chemotherapy
15. A new vision for integrated breast cancer
16. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer
17. Improving the accuracy of mammography: Volume and outcome relationships
18. Short-term breast cancer prediction by random periaredar fine-needle aspiration cytology and the Gail risk model
19. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI
20. Occult primary cancer with axillary metastases
21. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
22. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients
23. Contrast-enhanced magnetic resonance imaging of the breast
24. Technical report of the international working group on breast MRI
25. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
26. Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast
27. MR imaging of the breast with Gd-DTPA: Use and limitations
28. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging
29. High resolution 3D maps of contrast enhancement patterns in breast tumors
30. Imaging techniques for breast MR imaging
31. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA Preliminary observations
32. Occult cancer in women with dense breasts: Detection with screening US-diagnostic yield and tumor characteristics
33. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results
34. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique
35. Assessment of local recurrence after breast-conserving therapy with MRI
36. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma
37. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with phammcokinetic analysis of gadolinium-DPTA uptake in the diagnosis of local recurrence of early stage breast carcinoma
38. Breast cancer screening with mammography: Overview of Swedish randomised trials
39. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
40. Three-dimensional gadolinium-enhanced MR imaging of the breast: Pulse sequence with fat suppression and magnetization transfer contrast. Work in progress
41. Magnetic resonance imaging screening in women at genetic risk of breast cancer: Imaging and analysis protocol for the UK multicenter study
42. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma
43. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma
44. Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast
45. MR imaging of the breast in patients with invasive lobular carcinoma
46. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing
47. The additional value of US to mammography in the diagnosis of breast cancer
48. Fifteen-year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast
49. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles
50. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions
51. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1973 patients
52. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer